Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
about
Pharmacotherapy for anxiety and comorbid alcohol use disordersIllicit dopamine transients: reconciling actions of abused drugsA Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.Correlates of improvement in substance abuse among dually diagnosed veterans with post-traumatic stress disorder in specialized intensive VA treatmentAntidepressant-like effects of guanfacine and sex-specific differences in effects on c-fos immunoreactivity and paired-pulse ratio in male and female miceGlutamatergic mechanisms of comorbidity between acute stress and cocaine self-administrationA Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.Post-traumatic stress disorder and opioid use disorder: A narrative review of conceptual models.Concurrent Treatment of Substance Use and PTSD.Neurobiology of comorbid post-traumatic stress disorder and alcohol-use disorder.Posttraumatic Stress Disorder and Alcohol Use Disorder: A Critical Review of Pharmacologic Treatments.Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial.Interaction between noradrenergic and cholinergic signaling in amygdala regulates anxiety- and depression-related behaviors in mice.Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder
P2860
Q24186575-06F5754D-F65B-4D92-A902-120A644A6449Q26997102-E982EE56-CA38-4378-90F8-2D778F82ED98Q28068256-0D29F1CD-FCDA-4BC1-BC50-C8C13EED41A8Q34098366-77322AD4-3D4C-46D6-8081-C27E42AD169EQ34669057-B14760A1-FAB8-4170-A22F-54CB2936DA1AQ35804723-63266372-C118-4313-98C3-26F3C5B8B899Q36032783-225A4413-EA9E-41D2-848D-64E378688011Q36772392-A4ADF23D-C5B3-4A7D-8E4F-896DC7866E09Q37580733-397D434F-CBB9-4644-8BF3-35BB5DA19BC4Q38787311-28F0985C-143C-4331-B91D-92501A92D90AQ38859526-535F6F05-E6FD-4240-B453-BF712B845A16Q38982604-8C464B6F-DDDE-40F3-A7B3-CB3D7931395AQ39094898-D21A1077-02BE-47BF-96EA-32709BE826EFQ49489035-B8AB3087-FB1F-458E-8238-72B04D73A6A1Q52689099-3DE92168-F6F0-46A7-8328-927AE368C3B5Q57172126-1F6217A3-7516-47D0-BCA9-B52710DED6DC
P2860
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@ast
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@en
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@nl
type
label
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@ast
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@en
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@nl
prefLabel
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@ast
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@en
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@nl
P2860
P921
P1433
P1476
Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress
@en
P2093
Ismene Petrakis
Mehmet Sofuoglu
P2860
P304
P356
10.1016/J.ADDBEH.2013.08.014
P407
P577
2014-02-01T00:00:00Z